Evidence map›Paper›PMID 23490339›Full record

ArticleJournal of cellular and molecular medicine2013

Changes of lysosomes in the earliest stages of the development of atherosclerosis.

Yuri V Bobryshev, Tatyana A Shchelkunova, Ivan A Morozov, Petr M Rubtsov, Igor A Sobenin, Alexander N Orekhov, Alexander N Smirnov

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. CD68/macrosialin: not just a histochemical marker.Laboratory investigation; a journal of technical methods and pathology · 2017
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Yuri V BobryshevFaculty of Medicine, School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. y.bobryshev@unsw.edu.au
Tatyana A Shchelkunova
Ivan A Morozov
Petr M Rubtsov
Igor A Sobenin
Alexander N Orekhov
Alexander N Smirnov
Engelhardt Institute of Molecular Biology · RULomonosov Moscow State University · RUCamden and Campbelltown Hospitals · AUInstitute for Atherosclerosis Research · RUResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of hypotheses of atherosclerosis is based on a presumption that the zones prone to the development of atherosclerosis contain lysosomes which are characterized by enzyme deficiency and thus, are unable to dispose of lipoproteins. The present study was undertaken to investigate the characteristics and changes of lysosomes in the earliest stages of the development of atherosclerosis. Electron microscopic immunocytochemistry revealed that there were certain changes in the distribution of CD68 antigen in lysosomes along the 'normal intima-initial lesion-fatty streak' sequence. There were no significant changes found in the key mRNAs encoding for the components of endosome/lysosome compartment in initial atherosclerotic lesions, but in fatty streaks, the contents of EEA1 and Rab5a mRNAs were found to be diminished while the contents of CD68 and p62 mRNAs were increased, compared with the intact tissue. The study reinforces a view that changes occurring in lysosomes play a role in atherogenesis from the very earlier stages of the disease.

Indexed as

AdultAntigens, CDAntigens, Differentiation, MyelomonocyticAtherosclerosisCD68 MoleculeCell CompartmentationEndosomesFemaleHumansImmunohistochemistryLysosomesMaleMiddle AgedRNA, MessengerTunica IntimaAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 antigen, humanCD68 MoleculeRNA, Messenger

Identifiers

PMID23490339
PMCPMC3822815
OpenAlexW1992402942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.